( MENAFN - PR Newswire) ENGLEWOOD, Colo., July 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that effective as of open on July 14, 2021, its common stock has been approved for uplisting to the Global Select Market® and will continue trading under its current ticker symbol "ZYXI." The Nasdaq Global Select Market® is a mark of achievement and stature for qualified companies. Listed companies must meet financial and liquidity requirements and satisfy corporate governance and disclosure requirements on both an initial and continuing basis. "Meeting the requirements for the Nasdaq Global Select Market® demonstrates our strong growth and financial performance in recent years," said Thomas Sandgaard, CEO of Zynex.